Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.

Marcillo A, Frydel B, Bramlett HM, Dietrich WD.

Exp Neurol. 2012 Feb;233(2):687-92. doi: 10.1016/j.expneurol.2011.06.008. Epub 2011 Nov 10.

2.

Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury.

Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L, Takano T, Tian GF, Goldman SA, Nedergaard M.

Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12489-93. doi: 10.1073/pnas.0902531106. Epub 2009 Jul 27.

3.

A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury.

Pinzon A, Marcillo A, Pabon D, Bramlett HM, Bunge MB, Dietrich WD.

Exp Neurol. 2008 Sep;213(1):129-36. doi: 10.1016/j.expneurol.2008.05.018. Epub 2008 Jul 14.

4.

A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model.

Pinzon A, Marcillo A, Quintana A, Stamler S, Bunge MB, Bramlett HM, Dietrich WD.

Brain Res. 2008 Dec 3;1243:146-51. doi: 10.1016/j.brainres.2008.09.047. Epub 2008 Sep 24.

5.

Localized inhibition of P2X7R at the spinal cord injury site improves neurogenic bladder dysfunction by decreasing urothelial P2X3R expression in rats.

Munoz A, Yazdi IK, Tang X, Rivera C, Taghipour N, Grossman RG, Boone TB, Tasciotti E.

Life Sci. 2017 Feb 15;171:60-67. doi: 10.1016/j.lfs.2016.12.017. Epub 2016 Dec 27.

PMID:
28039004
6.

P2X7 receptor inhibition increases CNTF in the subventricular zone, but not neurogenesis or neuroprotection after stroke in adult mice.

Kang SS, Keasey MP, Hagg T.

Transl Stroke Res. 2013 Oct;4(5):533-45. doi: 10.1007/s12975-013-0265-2.

7.

Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats.

Wang YC, Cui Y, Cui JZ, Sun LQ, Cui CM, Zhang HA, Zhu HX, Li R, Tian YX, Gao JL.

Mol Med Rep. 2015 Aug;12(2):2149-54. doi: 10.3892/mmr.2015.3607. Epub 2015 Apr 14.

PMID:
25873133
8.

P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.

Messemer N, Kunert C, Grohmann M, Sobottka H, Nieber K, Zimmermann H, Franke H, Nörenberg W, Straub I, Schaefer M, Riedel T, Illes P, Rubini P.

Neuropharmacology. 2013 Oct;73:122-37. doi: 10.1016/j.neuropharm.2013.05.017. Epub 2013 May 28.

PMID:
23727220
9.

Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus.

Chu K, Yin B, Wang J, Peng G, Liang H, Xu Z, Du Y, Fang M, Xia Q, Luo B.

J Neuroinflammation. 2012 Apr 18;9:69. doi: 10.1186/1742-2094-9-69.

10.

Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.

Ryu JK, Jantaratnotai N, Serrano-Perez MC, McGeer PL, McLarnon JG.

J Neuropathol Exp Neurol. 2011 Jan;70(1):13-22. doi: 10.1097/NEN.0b013e318201d4d4.

PMID:
21157381
11.

Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat.

Bohár Z, Nagy-Grócz G, Fejes-Szabó A, Tar L, László AM, Büki A, Szabadi N, Vraukó V, Vécsei L, Párdutz Á.

J Neural Transm (Vienna). 2015 Dec;122(12):1621-31. doi: 10.1007/s00702-015-1445-x. Epub 2015 Aug 23.

PMID:
26298729
12.

P2X7 receptor inhibition improves recovery after spinal cord injury.

Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q, Liu QS, Goldman SA, Nedergaard M.

Nat Med. 2004 Aug;10(8):821-7. Epub 2004 Jul 18.

PMID:
15258577
13.

Microglial P2X₇ receptor in the hypothalamic paraventricular nuclei contributes to sympathoexcitatory responses in acute myocardial infarction rat.

Du D, Jiang M, Liu M, Wang J, Xia C, Guan R, Shen L, Ji Y, Zhu D.

Neurosci Lett. 2015 Feb 5;587:22-8. doi: 10.1016/j.neulet.2014.12.026. Epub 2014 Dec 15.

PMID:
25524407
14.

P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.

Arbeloa J, Pérez-Samartín A, Gottlieb M, Matute C.

Neurobiol Dis. 2012 Mar;45(3):954-61. doi: 10.1016/j.nbd.2011.12.014. Epub 2011 Dec 11.

PMID:
22186422
15.

A reassessment of a classic neuroprotective combination therapy for spinal cord injured rats: LPS/pregnenolone/indomethacin.

Popovich PG, Tovar CA, Wei P, Fisher L, Jakeman LB, Basso DM.

Exp Neurol. 2012 Feb;233(2):677-85. doi: 10.1016/j.expneurol.2011.11.045. Epub 2011 Dec 8.

16.

P2X(7) inhibition in stellate ganglia prevents the increased sympathoexcitatory reflex via sensory-sympathetic coupling induced by myocardial ischemic injury.

Tu G, Li G, Peng H, Hu J, Liu J, Kong F, Liu S, Gao Y, Xu C, Xu X, Qiu S, Fan B, Zhu Q, Yu S, Zheng C, Wu B, Peng L, Song M, Wu Q, Liang S.

Brain Res Bull. 2013 Jul;96:71-85. doi: 10.1016/j.brainresbull.2013.05.004. Epub 2013 May 17.

PMID:
23688519
17.

Independent evaluation of the effects of glibenclamide on reducing progressive hemorrhagic necrosis after cervical spinal cord injury.

Popovich PG, Lemeshow S, Gensel JC, Tovar CA.

Exp Neurol. 2012 Feb;233(2):615-22. doi: 10.1016/j.expneurol.2010.11.016. Epub 2010 Dec 9.

18.

Forced exercise as a rehabilitation strategy after unilateral cervical spinal cord contusion injury.

Sandrow-Feinberg HR, Izzi J, Shumsky JS, Zhukareva V, Houle JD.

J Neurotrauma. 2009 May;26(5):721-31. doi: 10.1089/neu.2008.0750.

19.

Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.

Wang XH, Xie X, Luo XG, Shang H, He ZY.

Mol Med Rep. 2017 Feb;15(2):768-776. doi: 10.3892/mmr.2016.6070. Epub 2016 Dec 23.

20.

Prophylactic systemic P2X7 receptor blockade prevents experimental colitis.

Marques CC, Castelo-Branco MT, Pacheco RG, Buongusto F, do Rosário A Jr, Schanaider A, Coutinho-Silva R, de Souza HS.

Biochim Biophys Acta. 2014 Jan;1842(1):65-78. doi: 10.1016/j.bbadis.2013.10.012. Epub 2013 Oct 30.

Supplemental Content

Support Center